View in EDS HTML Full Text PDF Full Text

Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.
Authors: Lu, Yunxin1,2 (AUTHOR) luyx@sysucc.org.cn, Lin, Qingguang2,3 (AUTHOR) linqg@sysucc.org.cn, Mo, Yongxin1,2 (AUTHOR) moyx2@sysucc.org.cn, Liu, Furong2,4 (AUTHOR) liufr@sysucc.org.cn, Zhang, Mengwei1,2 (AUTHOR) zhangmw@sysucc.org.cn, Huang, Runjie1,2 (AUTHOR) huangrj@sysucc.org.cn, Wang, Yun1,2 (AUTHOR) wangyun1@sysucc.org.cn, Wang, Yinnan1,2 (AUTHOR) wangyn@sysucc.org.cn, Wang, Zhiqiang1,2 (AUTHOR) wangzhq@sysucc.org.cn, Luo, Huiyan1,2 (AUTHOR) luohy@sysucc.org.cn, Guo, Guifang2,5 (AUTHOR) guogf@sysucc.org.cn, Chen, Jianwen1,2 (AUTHOR) chenjianw@sysucc.org.cn, Liu, Yu2,4 (AUTHOR) liuyu@sysucc.org.cn, He, Mingming1,2 (AUTHOR) hemm@sysucc.org.cn, Wang, Fenghua1,2 (AUTHOR) wangfh@sysucc.org.cn, Wang, Feng1,2 (AUTHOR) wangfeng@sysucc.org.cn, Zhang, Dongsheng1,2 (AUTHOR) zhangdsh@sysucc.org.cn
Source: Molecular Cancer. 10/2/2025, Vol. 24 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 188450310
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lu%2C+Yunxin%22">Lu, Yunxin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> luyx@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Lin%2C+Qingguang%22">Lin, Qingguang</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<i> linqg@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Mo%2C+Yongxin%22">Mo, Yongxin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> moyx2@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Liu%2C+Furong%22">Liu, Furong</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<i> liufr@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Mengwei%22">Zhang, Mengwei</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> zhangmw@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Huang%2C+Runjie%22">Huang, Runjie</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> huangrj@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Yun%22">Wang, Yun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> wangyun1@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Yinnan%22">Wang, Yinnan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> wangyn@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhiqiang%22">Wang, Zhiqiang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> wangzhq@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Luo%2C+Huiyan%22">Luo, Huiyan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> luohy@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Guo%2C+Guifang%22">Guo, Guifang</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<i> guogf@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Chen%2C+Jianwen%22">Chen, Jianwen</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> chenjianw@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Liu%2C+Yu%22">Liu, Yu</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<i> liuyu@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22He%2C+Mingming%22">He, Mingming</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> hemm@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Fenghua%22">Wang, Fenghua</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> wangfh@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Feng%22">Wang, Feng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> wangfeng@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Dongsheng%22">Zhang, Dongsheng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> zhangdsh@sysucc.org.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Cancer%22">Molecular Cancer</searchLink>. 10/2/2025, Vol. 24 Issue 1, p1-17. 17p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188450310
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12943-025-02437-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 17
        StartPage: 1
    Titles:
      – TitleFull: Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lu, Yunxin
      – PersonEntity:
          Name:
            NameFull: Lin, Qingguang
      – PersonEntity:
          Name:
            NameFull: Mo, Yongxin
      – PersonEntity:
          Name:
            NameFull: Liu, Furong
      – PersonEntity:
          Name:
            NameFull: Zhang, Mengwei
      – PersonEntity:
          Name:
            NameFull: Huang, Runjie
      – PersonEntity:
          Name:
            NameFull: Wang, Yun
      – PersonEntity:
          Name:
            NameFull: Wang, Yinnan
      – PersonEntity:
          Name:
            NameFull: Wang, Zhiqiang
      – PersonEntity:
          Name:
            NameFull: Luo, Huiyan
      – PersonEntity:
          Name:
            NameFull: Guo, Guifang
      – PersonEntity:
          Name:
            NameFull: Chen, Jianwen
      – PersonEntity:
          Name:
            NameFull: Liu, Yu
      – PersonEntity:
          Name:
            NameFull: He, Mingming
      – PersonEntity:
          Name:
            NameFull: Wang, Fenghua
      – PersonEntity:
          Name:
            NameFull: Wang, Feng
      – PersonEntity:
          Name:
            NameFull: Zhang, Dongsheng
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: 10/2/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 14764598
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular Cancer
              Type: main
ResultId 1